Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gabriele Siciliano is active.

Publication


Featured researches published by Gabriele Siciliano.


Neurology | 2004

A novel mitochondrial tRNAPhe mutation causes MERRF syndrome.

Michelangelo Mancuso; Massimiliano Filosto; Vamsi K. Mootha; Anna Rocchi; Sabina Pistolesi; Luigi Murri; Salvatore DiMauro; Gabriele Siciliano

A woman with typical features of myoclonic epilepsy with ragged red fibers (MERRF) had a novel heteroplasmic mutation (G611A) in the mitochondrial DNA tRNA phenylalanine gene. The mutation was heteroplasmic (91%) in muscle but undetectable in accessible tissues from the patient and her maternal relatives. Single-fiber PCR analysis showed that the proportion of mutant genomes was higher in cytochrome c oxidase (COX)-negative ragged red fibers (RRFs) than in COX-positive non-RRFs. This report shows that typical MERRF syndrome is not always associated with tRNA lysine mutations.


Human Genomics | 2008

Mitochondrial DNA sequence variation and neurodegeneration

Michelangelo Mancuso; Massimiliano Filosto; Daniele Orsucci; Gabriele Siciliano

Mitochondria, the powerhouse of the cell, play a critical role in several metabolic processes and apoptotic pathways. Many lines of evidence suggest that mitochondria have a central role in ageing-related neurodegenerative diseases. Moreover, there is a long history of investigations on mitochondria aimed at identifying genetic markers relating to ageing and neurodegenerative diseases. In this review, some of the major neurodegenerative disorders are highlighted and the role of mitochondrial haplogroups in the pathogenetic cascade leading to these diseases is discussed.


Current Molecular Medicine | 2014

Amyotrophic Lateral Sclerosis: A Genetic Point Of View.

Cecilia Carlesi; E. Caldarazzo Ienco; Michelangelo Mancuso; Gabriele Siciliano

In the last twenty years the rapid advances in neurogenetic have revolutionized not only the molecular, pathological, inheritance but also the clinical concept of ALS. Here we review the current genetic breakthrough in familial and sporadic ALS, considering how this knowledge has allowed widening of the scenario on the possible pathogenic disease mechanisms and better understanding of the relationship between the genetic, pathological and clinical subtypes.


Archive | 2016

Nrf2 Signaling: An Adaptive Response Pathway for Neurodegenerative Disorders

Annalisa Lo Gerfo; Lucia Petrozzi; Lucia Chico; Gabriele Siciliano

Oxidative damage contributes to pathogenesis in many neurodegenerative diseases. As the indicator and regulator of oxidative stress, the nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) pathway has been shown to have dynamic changes and examined for its neuroprotective role in many cases. Nrf2 is emerging as a regulatory protein in neuronal death, since it helps neuronal cells to meet with oxidative insults. In this chapter, we summarize the role of Nrf2 as a master regulator of oxidative stress. Furthermore, we treat some natural and chemical substances able to modulate the Nrf2 pathway and, therefore, their possible use in the neurodegenerative diseases therapeutic treatment.


Neuromuscular Disorders | 2012

The indistinct borders between psychological motivation, self-esteem, stress response and pain underline this assumption.

Gabriele Siciliano; T. Mongini; Antonio Toscano

The current legal regime distinguishes between different types and categories of data. In general, the more personal, private and sensitive data are, the higher the level of protection provided. Among others, the legal regime differentiates between non-personal data and personal data, between metadata and content data and between nonsensitive and sensitive personal data. But there are at least three reasons why these legal categories may become redundant in the age of Big Data, artificial intelligence and increasing computational power.


Archive | 2009

The Role of Mitochondria in StemCell Biology

Claudia Nesti; Livia Pasquali; Michelangelo Mancuso; Gabriele Siciliano


Neuromuscular Disorders | 2017

P.267 - Clinical variability in myotonic dystrophy type 1: a five-categories disease classification fits clinical but not brain complexity

Sigrid Baldanzi; Costanza Simoncini; Giulia Ricci; C. Angelini; Gabriele Siciliano


Neuromuscular Disorders | 2017

Report on nationwide Italian collaborative network for muscle glycogen storage disorders

Olimpia Musumeci; T. Mongini; C. Angelini; C. Bruno; M. Moggio; Gabriele Siciliano; Paola Tonin; Lorenzo Maggi; Andrea Martinuzzi; Massimiliano Filosto; Serenella Servidei; A. Donati; Bruno Bembi; Antonio Toscano


ACTA MYOLOGICA | 2016

Hard ways towards adulthood: the transition phase in young people with myotonic dystrophy

Sigrid Baldanzi; Giulia Ricci; Costanza Simoncini; Mirna Cosci O Di Coscio; Gabriele Siciliano


Neuromuscular Disorders | 2015

Clinical and molecular features of a large cohort of Italian McArdle patients

Denise Cassandrini; Paola Tonin; Lucia Morandi; Olimpia Musumeci; Massimiliano Filosto; Gabriele Siciliano; Elena Pegoraro; Lucio Santoro; Roberto Massa; Tiziana Mongini; M. Sacchini; Enrico Bertini; Giovanni Marrosu; Miriam Rigoldi; A. Burlina; Antonella Pini; Stefano C. Previtali; Filippo M. Santorelli; Antonio Toscano; C. Bruno

Collaboration


Dive into the Gabriele Siciliano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge